These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3785472

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H, Grossberg GT.
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
    Korczyn AD.
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT.
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Therapeutic progress--review XVIII Alzheimer's disease.
    Kendall MJ, Chellingsworth MC, Main AN.
    J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
    Boller F, Orgogozo JM.
    Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z, Davidson M, Davis KL.
    Harefuah; 1987 Dec 15; 113(12):401-4. PubMed ID: 3330722
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cholinergic drugs, affective disorders and dementia: problems of clinical research.
    Spiegel R.
    Acta Psychiatr Scand Suppl; 1991 Dec 15; 366():66-9. PubMed ID: 1897378
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Muscarinic agonists for senile dementia: past experience and future trends.
    Gray JA, Enz A, Spiegel R.
    Trends Pharmacol Sci; 1989 Dec 15; Suppl():85-8. PubMed ID: 2694530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.